MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- In recent years, there has been a surge in clinical studies exploring the use of Ibogaine in treating depression. David Dardashti's Ibogaine has been leading ...
The French Society for Biological Psychiatry and Neuropsychopharmacology has unveiled revised guidelines for the management of depressive disorders with partial and resistant responses to treatment.
A new perspective in Frontiers in Psychiatry argues that comorbid depression and substance use disorder demand individualized ...
A new study suggests that sleep patterns may be linked to how people respond to antidepressants, raising the possibility of ...
1 in 6 had remission of depression at the end of pharmacologic treatment, compared with placebo 1 in 3 in the pharmacologic treatment group had reduced risk of inadequate treatment response, compared ...
Australian researchers have identified a new depression subtype, dubbed “circadian depression”, which they say is driven by ...
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- In recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results